Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials

L Klokker; DB Berthelsen; T Woodworth; KM Andersen; DE Furst; D Devoe; PR Williamson; ME Suarez-Almazor; V Strand; AL Leong; N Goel; M Boers; PM Brooks; L March; VS Sloan; P Tugwell; LS Simon; R Christensen

Journal article

Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials

L Klokker, DB Berthelsen, T Woodworth, KM Andersen, DE Furst, D Devoe, PR Williamson, ME Suarez-Almazor, V Strand, AL Leong, N Goel, M Boers, PM Brooks, L March, VS Sloan, P Tugwell, LS Simon, R Christensen

Journal of Rheumatology | J RHEUMATOL PUBL CO | Published : 2019

DOI: 10.3899/jrheum.190196

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Safety Working Group objective was to identify harm domains from existing outcome measurements in rheumatology. Methods. Systematically searching the MEDLINE database on January 24, 2017, we identified full-text articles that could be used for harm outcomes in rheumatology. Domains/items from the identified instruments were described and the content synthesized to provide a preliminary framework for harm outcomes. Results. From 435 possible references, 24 were read in full text and 9 were included: 7 measurement instruments were identified. Investigation of domains/items revealed considerable heterogeneity in the grouping and approach..

View full abstract